News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Warnex Inc.'s Bioanalytical Services Division Acquires Two State-of-the-Art TSQ Vantage Mass Spectrometers
October 16, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LAVAL, QUEBEC--(Marketwire - October 16, 2008) - Warnex Inc. (TSX: WNX) announced today that its Bioanalytical Services division has acquired two state-of-the-art TSQ Vantage mass spectrometers from Thermo Fisher Scientific Inc.
Twitter
LinkedIn
Facebook
Email
Print
Thermo Fisher Scientific